Patents by Inventor Tama Bloch

Tama Bloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutritional supplement powder
    Patent number: 10912323
    Abstract: A nutritional supplement powder and a method of making the nutritional supplement powder are provided. The nutritional supplement powder includes from 20% by weight to 55% by weight protein, from 20% by weight to 50% by weight fructooligosaccharide powder, and an anti-caking mixture that includes calcium silicate and tricalcium phosphate. A weight ratio of the fructooligosaccharide powder to the anti-caking mixture is from 6:1 to 10:1.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: February 9, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Deborah Strozier, Ronald McKenna, Tama Bloch, Kuochu Li
  • NUTRITIONAL SUPPLEMENT POWDER
    Publication number: 20190328021
    Abstract: A nutritional supplement powder and a method of making the nutritional supplement powder are provided. The nutritional supplement powder includes from 20% by weight to 55% by weight protein, from 20% by weight to 50% by weight fructooligosaccharide powder, and an anti-caking mixture that includes calcium silicate and tricalcium phosphate. A weight ratio of the fructooligosaccharide powder to the anti-caking mixture is from 6:1 to 10:1.
    Type: Application
    Filed: February 28, 2017
    Publication date: October 31, 2019
    Applicant: ABBOTT LABORATORIES
    Inventors: DEBORAH STROZIER, RONALD MCKENNA, TAMA BLOCH, KUOCHU LI
  • PRENATAL AND LACTATION SUPPLEMENTS TO ENHANCE CENTRAL NERVOUS SYSTEM DEVELOPMENT OF OFFSPRING
    Publication number: 20160022710
    Abstract: Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-lutein. The supplements may enhance central nervous system development in a fetus or breast-feeding newborn infant.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Applicant: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, Tama Bloch, Christina Sherry, Maria Ramirez Gonzalez, Matthew Kuchan, Gary Katz, Elena Oliveros Delgado, Angela Santos